Colchicine and Post-COVID-19 Pulmonary Fibrosis

PHASE4UnknownINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

August 25, 2021

Study Completion Date

October 20, 2023

Conditions
Covid19Pulmonary Fibrosis Interstitial
Interventions
DRUG

Colchicine 0.5 MG

colchicine 0.5 mg (2 tablets: 1 mg) twice per day as a loading dose, followed by one tablet 0.5 twice per day for three weeks in addition to the standard protocol

OTHER

the standard protocol only

the local standard protocol for COVID19

Trial Locations (1)

Unknown

El-Demerdash Hospital, Cairo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ClinAmygate

OTHER

NCT04818489 - Colchicine and Post-COVID-19 Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter